Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus

CD8 ⁺ Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication

1986 • 1,010 citations

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

1985 • 789 citations

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

1990 • 593 citations

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1992 • 481 citations

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

1997 • 364 citations

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

1991 • 357 citations

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay

1992 • 353 citations

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1996 • 299 citations

Techniques in HIV Research

1990 • 263 citations

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

1994 • 214 citations

CD8⁺Cell Anti-HIV Activity: Nonlytic Suppression of Virus Replication

1992 • 194 citations

A Single Amino Acid Interchange Yields Reciprocal CTL Specificities for HIV-1 gp160

1989 • 181 citations

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1990 • 156 citations

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1997 • 155 citations

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.

1989 • 144 citations

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate

1996 • 137 citations

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1997 • 131 citations

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1994 • 110 citations

Protection of MN-rgp120-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1

1996 • 100 citations

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1

1995 • 97 citations

Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal Administration

1994 • 81 citations

Vaccinia Virus Expression Vector: Coexpression of β-Galactosidase Provides Visual Screening of Recombinant Virus Plaques

1985 • 76 citations

Human Immunodeficiency Virus Type 1 Neutralizing Antibody Serotyping Using Serum Pools and an Infectivity Reduction Assay

1996 • 72 citations

Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees

1998 • 69 citations

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates

1992 • 68 citations

Generation of CD8 suppressor factor and β chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques

1998 • 66 citations

Immunogenicity of Recombinant Human Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees

1993 • 58 citations

Induction of HIV‐1 envelope (gp120)‐specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell‐derived gp120 is enhanced by enzymatic removal of N‐linked glycans

1994 • 54 citations

Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2

1995 • 50 citations

Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model.

1992 • 50 citations

NASBA: A Novel, Isothermal Detection Technology for Qualitative and Quantitative HIV-1 RNA Measurements

1996 • 47 citations

CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine Efficacy

1999 • 26 citations

Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.

1991 • 16 citations

Humoral and Cellular Immune Responses in Rhesus Macaques Infected with Human Immunodeficiency Virus Type 2

1995 • 16 citations

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection

1996 • 16 citations

Neutralizing Antibodies

1990 • 7 citations